Nucleate Germany / Global Virtual Activator 2026–2027

Nucleate

HIGH T3 Founder

Strategy Notes

Global Virtual option removes location barrier pre-EDITH. Life sciences focus fits computational pharmacology. Post-EDITH, Germany chapter directly accessible. Imprint MVP + CCT preprints satisfy 'preliminary POC data' requirement.

Key Materials

Application via nucleate.org/activator. Technology/project description, team composition, scientific foundation.

Gate / Eligibility

Academic trainee (PhD/MS/Postdoc/MD) or early professional. No equity taken. MSc student qualifies.

Your Notes

Status & Deadline

Status: HUMAN_REQUIRED
Deadline: ~October 2026 (check nucleate.org in Aug–Sept 2026)
Cycle: Annual
Amount: Equity-free. Stipend possible via some chapters. Main value: network + mentorship.
Type: Accelerator (equity-free)
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 UPCOMING → HUMAN_REQUIRED · Step 1 — Contact Nucleate directly (hq@nucleate.org or the Global Virtual chapter lead) before August 2026 to confirm whether an independent, non-academic founder qualifies under the 'early-career professional' eligibility category without a PI. Step 2 — If a PI/sponsor letter is required, secure a formal collaborating academic at Institut Pasteur or I2BC (Paris-Saclay) willing to write a letter; this is feasible given the named partnership pipeline. Step 3 — Once eligibility is confirmed, submit the web-form application at apply.nucleate.org (Global Virtual chapter) before the October 20 2026 deadline. Interviews of shortlisted teams occur November–December 2026; cohort runs January–June 2027.